Can training therapists in LGBTQ-Affirmative CBT ease depression in marginalized communities?

NCT ID NCT05890404

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial investigates how to best implement LGBTQ-affirmative cognitive-behavioral therapy (CBT) at LGBTQ community centers across the United States. It compares two training approaches for mental health providers: one with self-guided online materials only, and another that adds live weekly training sessions. The study will measure whether these training methods improve providers' fidelity to the therapy and, in turn, reduce depression symptoms in their sexual and gender minority clients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
LGBTQ-affirmative cognitive-behavioral therapy (CBT) training for providers, delivered either as self-guided materials alone or with additional live training sessions
What this could lead to
If successful, this could establish effective ways to bring LGBTQ-affirmative mental health care to community centers nationwide, improving depression outcomes for sexual and gender minority individuals.
What could go wrong
The trial focuses on training providers, not directly on clients, so benefits may vary. It is also a large implementation study, and results may depend on how well community centers adopt the training.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CBT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Yale LGBTQ Mental Health Initiative with the Yale School of Public Office

    New York, New York, 10001, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.